This inventor holds 1 USPTO granted patent. Top assignees: Institut De Recherche Pour Le Development (Ird), Institut Pasteur. Active years: 2013.
Company Filing History:
1 out of 5 
1 out of 897 
Years Active: 2013
Title: Thomas Lavstsen: Innovator in Gestational Malaria Research
Introduction
Thomas Lavstsen is a notable inventor based in Hoersholm, Denmark. He has made significant contributions to the field of gestational malaria through his innovative research and patenting efforts. His work focuses on the development of novel antigens and immunogenic compositions aimed at combating this serious health issue.
Latest Patents
Thomas Lavstsen holds a patent related to "Polynucleotides and polypeptides involved in gestational malaria, and biological applications." This patent provides novel antigens involved in gestational malaria, specifically detailing polynucleotide and polypeptide sequences, conjugates, and cloning vectors. These sequences are crucial for the preparation of immunogenic compositions and vaccines, as well as antibodies for treating gestational malaria. Additionally, the patent describes various diagnostic methods and kits that can be utilized in this context.
Career Highlights
Throughout his career, Thomas has worked with prestigious institutions such as Institut Pasteur and the Institut de Recherche pour le Développement (IRD). His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Thomas Lavstsen's notable coworkers include Nicaise George Tuikue Ndam and Peter David. Their collaborative efforts have further advanced the understanding and treatment of gestational malaria.
Conclusion
Thomas Lavstsen's innovative work in the field of gestational malaria has led to significant advancements in the development of vaccines and diagnostic methods. His contributions are vital in the ongoing fight against this disease, showcasing the importance of research and innovation in public health.